COVID-19 Vaccine Update No 19
Published: 24 May 2021
Booking earlier second Covid-19 vaccine dose appointment (cohorts 1 – 9)
In line with JCVI and government guidance, the NHS is contacting people most at risk of getting seriously ill from coronavirus (cohorts 1-9) to book an earlier appointment for their second dose of the vaccine. People in this group will be able to have their second dose between 8 and 12 weeks instead of the 11 to 12 weeks specified in previous guidance. Guidance on this is available at: https://www.england.nhs.uk/c oronavirus/publication/covid-19-vaccinationaccelerating-second-doses-for-priority-cohorts-1-9/
As part of this, the National Booking Service is contacting people that booked through (www.nhs.uk/covid-vaccination or 119) to book an earlier appointment.
If an individual booked and received their first dose of the vaccine through a local service and not through the National Booking Service, the local NHS will contact them with details on booking their second dose. Communications materials for PCN led vaccinations services are available at: https://future.nhs.uk/P_C_N/view?objectId=101348773
How do people rebook through National Booking Service (NBS)?
People should wait to be contacted.
If people already have a second dose appointment that is soon we would recommend keeping that appointment. The NHS is working hard to ensure people in cohorts 1-9 can book an earlier appointment, at 8 weeks or as soon as possible after that. Where people want to book an earlier appointment, they should:
1. Go to www.nhs.uk/covid-vaccination and click on book or manage your Covid-19 vaccination
2. On the main booking page, click on manage my appointments
3. Enter your personal details and then the booking reference for your existing second dose appointment. This can be found in your text or email confirmation of your booking if you provided your contact details.
4. When you are in your appointment page, in order to book an earlier appointment, you will first need to cancel your existing appointment by clicking on cancel appointment. NOTE: It is not currently possible to see what other appointments are available until you have cancelled your existing appointment.
5. When you have cancelled your appointment you can book a new appointment. Any new appointments offered to you will be in line with the JCVI and government guidance, i.e they will be 8 weeks after your first dose appointment or as soon as possible after that.
People can also ring 119. Please note that call handlers in 119 use the same system to book appointments as is available on www.nhs.uk/covid-vaccination so the call handler will need to cancel the existing appointment before seeing what time, date and location options are available for booking an earlier appointment.
More than 900,000 people have now received first doses across Sussex
Latest data published today shows that more than 950,000 people have now received their first vaccination. This includes more than 90% of those aged 70 and over who have now had second dose, and more than 50% of those aged 60 and over who have had both. This week people aged 36 and 37 became eligible and are encouraged to use the national booking system to arrange an appointment. Anyone in this age group is encouraged to book their appointment through the national booking system online at nhs.uk or by calling 119.
Brighton to be part of world-first COVID-19 vaccine booster study
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial Health Secretary Matt Hancock announced yesterday. The Cov-Boost study, led by University Hospital Southampton NHS Foundation Trust and backed by £19.3 million of government funding through the Vaccines Taskforce, will trial seven vaccines and will be the first in the world to provide vital data on the impact of a third dose on patients’ immune responses. One of the 16 bases for the trials will be Brighton, at University Hospital Sussex. It will give scientists from around the globe and the experts behind the UK’s COVID-19 vaccination programme a better idea of the impact of a booster dose of each vaccine in protecting individuals from the virus. Vaccines being trialled include Oxford/AstraZeneca, Pfizer/BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac, as well as a control group. The trial has received ethics approval by the NHS Research Ethics Committee, as well as approval from the Medicines and Healthcare products Regulatory Agency. The study will open for applications from volunteers shortly via the study’s website and will be recruiting participants through the NHS COVID-19 Vaccine Research Registry. Participants will be adults aged 30 years or older as these will have been those immunised early on in the vaccination programme - for example, adults aged 75 and over or health and care workers.